This study seeks to search for molecular markers capable of predicting the activation of hypnozoites, unique and dormant forms of vivax malaria. To do so, a metabolomic approach will be used in samples from patients with a chance of recurrence in several malaria endemic areas. The project is innovative because it combines strict clinical follow-up and analysis of metabolites through the processing of samples using high sensitivity and resolution instrumentalization.